Document is current
Any future updates will be listed below
-
Authors
Hernandez, Rosmely
Põder, Janika
LaPorte, Kathryn M.
Malek, Thomas R. http://orcid.org/0000-0001-7174-0434
- License Information
-
More Information
Article History
Accepted: 18 January 2022
First Online: 25 February 2022
Competing interests
: The University of Miami, T.R.M. and R.H. have patents pending on IL-2–CD25 fusion proteins (Wo2016022671A1; T.R.M.) and their use (PCT/US20/13152; T.R.M. and R.H.) that have been licensed exclusively to Bristol Myers Squibb, and some research on IL-2–CD25 fusion proteins has been supported, in part, by a collaboration and sponsored research and licensing agreement with Bristol Myers Squibb. The other authors declare no competing interests.
